WHO WE ARE

CureGrail is a highly experienced team in the field of Type 2 diabetes, biostatistics, mathematics, supercomputing information technology, bio simulation, predictive analytics, gaming, behavioral economics, healthcare sociology, human psychology, global health, and healthcare leadership.

CureGrail supports The CureGrail Foundation, a private/public partnership creating a platform for T2D research for the public and private sector.

At CureGrail, our vision is to significantly improve the longevity and quality of life for the underserved healthcare community, starting with Type 2 diabetes. We are committed to collaborative solutions, leveraging our existing public-private partnerships with care partners to deliver high-tech, cost-effective care. By providing a path to fit diabetes management into their daily lives, we make a tangible difference in our patient's quality of life and health outcomes. CureGrail accomplishes this by continuously enhancing clinical care pathways through active patient engagement and our novel, groundbreaking AI technologies that drive predictive analytics.

A long-time physician friend often says, "Healthcare is the last bastion of Jurassic business." Today, CureGrail does not need to reinvent the wheel. Our approach and execution of patient engagement and the careful design of our predictive platform are areas where bold and creative thinking is required.

With the empowerment of AI learning models and rethinking personalized medicine, in 2021, CureGrail moved to a vision of reimagining population disease management in the underserved T2D healthcare population. However, the original mission of CureGrail remains the same. Our purpose is to save and enrich lives.